What is Cynaptec Pharmaceuticals worth?
$34.0Mlast known valuation
Cynaptec Pharmaceuticals last raised $6.0M in its Early Stage VC (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cynaptec Pharmaceuticals
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $6.0M | ▮ | ▮ |
How Cynaptec Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cynaptec Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Cynaptec Pharmaceuticals worth?
- Cynaptec Pharmaceuticals's last known valuation is $34.0M.
- How much has Cynaptec Pharmaceuticals raised?
- Cynaptec Pharmaceuticals has raised $6.0M in total funding across 1 recorded rounds.
- When did Cynaptec Pharmaceuticals last raise?
- Cynaptec Pharmaceuticals last raised in Apr 2025 (Early Stage VC), raising $6.0M.